RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Ty Ridenour

Ty A. Ridenour

Research Public Health Analyst


MPE, Psychiatric Epidemiology and Biostatistics, Washington University
PhD, School Psychology, concentrations in Neuropsychology, Counseling Psychology, and Statistics, Ball State University
MA, Educational Psychology, Ball State University
BS, Psychology, minors in English and History, Honors College, Ball State University

Ty A. Ridenour has two decades of clinical and research experience in etiology, assessment, and methodology related to disruptive behavior disorders, with the penultimate goal of improving prevention of these outcomes.  His areas of interest and contributions focus on developmental progressions in the behaviors and their risk factors, developing tools to facilitate translation of science into practice (prevention), and ages 8 to 13. 

A second concentration of his funded research is to develop methodologies to conduct rigorous analysis of longitudinal, within-person clinical trials using small samples.  His recent studies have demonstrated and highlighted the relative strengths and weaknesses of analytic techniques for detecting change within individuals over time, including trajectory analysis and state space modeling.  One objective of this work is to create tools and adapt data analytic techniques and other methodologies for practitioner uses for evidence-based, individualized treatment.

Before joining RTI, Dr. Ridenour was a faculty member of the Center for Education and Drug Abuse Research at the University of Pittsburgh, the Prevention Research Center at The Pennsylvania State University, and the Department of Psychiatry of Washington University in St. Louis. Since 1996, his continuous National Institutes of Health (NIH) funding has been to develop instrumentation for, and to investigate etiology of, pre-disorder substance use, particularly before and during adolescence. This work has required innovative instrumentation (for developmental appropriateness), integration of distinct theoretical orientations, and collaboration with multidisciplinary teams.

Dr. Ridenour has authored and co-authored more than 70 peer-reviewed journal articles on these and related research topics.


Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics